1. Circulating microRNAs and diabetes mellitus: a novel tool for disease prediction, diagnosis, and staging?
   G. Sebastiani et al, 2017, J Endocrinol Invest CrossRef
2. Plasma microRNA-16-5p, -17-5p and -20a-5p: Novel diagnostic biomarkers for gestational diabetes mellitus
   Ya-Lei Cao et al, 2017, J. Obstet. Gynaecol. Res. CrossRef
3. MicroRNAs in the pathogenesis of type 2 diabetes: new research progress and future direction.
   Chenggui Miao et al, 2017, Can. J. Physiol. Pharmacol. CrossRef
4. MicroRNA and Diabetic Complications- a clinical perspective
   Baoqi Fan et al, 2017, Antioxidants & Redox Signaling CrossRef
5. Microribonucleic acid-192 as a specific biomarker for the early diagnosis of diabetic kidney disease
   Xinyi Yang et al, 2017, J Diabetes Investig CrossRef
6. microRNAs in the pathophysiology of CKD-MBD: Biomarkers and innovative drugs
   Valérie Metzinger-Le Meuth et al, 2017, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
7. Role of miR-15a in intervertebral disc degeneration through targeting MAP3K9
   Ping Cai et al, 2017, Biomedicine & Pharmacotherapy CrossRef
8. Therapeutic potential of microRNAs for the treatment of renal fibrosis and CKD.
   Wenshan Lv et al, 2018, Physiol Genomics CrossRef
9. Identification of stress-related microRNA biomarkers in type 2 diabetes mellitus: A systematic review and meta-analysis
   Ying-Zhi Liang et al, 2018, Journal of Diabetes CrossRef
10. MicroRNA and Microvascular Complications of Diabetes
    F. Barutta et al, 2018, International Journal of Endocrinology CrossRef
11. Role of microRNA in diabetic cardiomyopathy: From mechanism to intervention
    Rui Guo et al, 2017, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
12. MicroRNAs and diabetic kidney disease: Systematic review and bioinformatic analysis
    Taís S. Assmann et al, 2018, Molecular and Cellular Endocrinology CrossRef
13. Association of Elevated Urinary miR-126, miR-155, and miR-29b with Diabetic Kidney Disease
    Cristina Beltrami et al, 2018, The American Journal of Pathology CrossRef
14. Identification of candidate microRNA biomarkers in diabetic nephropathy: a meta-analysis of profiling studies
    Alieh Gholaminejad et al, 2018, J Nephrol CrossRef
15. Upregulation of MiR-126 Delays the Senescence of Human Glomerular Mesangial Cells Induced by High Glucose via Telomere-p53-p21-Rb Signaling Pathway
    Dong-wei Cao et al, 2018, CURR MED SCI CrossRef
16. MicroRNAs: new biomarkers and promising therapeutic targets for diabetic kidney disease
    Linicene Rosa do Nascimento et al, 2019, J. Bras. Nefrol. CrossRef
17. MicroRNAs in the Progress of Diabetic Nephropathy: A Systematic Review and Meta-Analysis.
    Li-Ping Wang et al, 2019, Evid Based Complement Alternat Med CrossRef
18. Emerging Roles for MicroRNAs in Diabetic Microvascular Disease: Novel Targets for Therapy
    Yu Zhang et al, 2017 CrossRef
19. Role of tea polyphenols in delaying hyperglycemia-induced senescence in human glomerular mesangial cells via miR-126/Akt–p53–p21 pathways
    Dongwei Cao et al, 2019, Int Urol Nephrol CrossRef
20. Epigenetics of kidney disease
    Nicola Wanner et al, 2017, Cell Tissue Res CrossRef
21. Emerging Roles for MicroRNAs in Diabetic Microvascular Disease: Novel Targets for Therapy
    Yu Zhang et al, 2017 CrossRef
22. Interleukins and miRNAs intervene in the early stages of diabetic kidney disease in Type 2 diabetes mellitus patients
    Ligia Petrica et al, 2019, Biomarkers in Medicine CrossRef
23. MiRNA Expression is Associated with Clinical Variables Related to Vascular Remodeling in the Kidney and the Brain in Type 2 Diabetes Mellitus Patients
    Ligia Petrica et al, 2019, Endocrine Research CrossRef
24. The Role of MicroRNAs in the Pathogenesis of Diabetic Nephropathy
    Jian Tang et al, 2019, International Journal of Endocrinology CrossRef
25. Simultaneous Assessment of MicroRNAs 126 and 192 in Diabetic Nephropathy Patients and the Relation of these MicroRNAs with Urinary Albumin
    Safaa I. Tayel et al, 2020, CMM CrossRef
26. Expression of microRNA‑377 and microRNA‑192 and their potential as blood‑based biomarkers for early detection of type 2 diabetic nephropathy
    Ghada Al‑Kafaji et al, 2018, Mol Med Report CrossRef
27. Non-coding RNAs and type 2 diabetes mellitus
    Mohammad Taheri et al, 2020, Archives of Physiology and Biochemistry CrossRef
28. Research Status of Differentially Expressed Noncoding RNAs in Type 2 Diabetes Patients
    Rou Shi et al, 2020, BioMed Research International CrossRef
29. A CMOS-Based Capacitive Biosensor for Detection of a Breast Cancer MicroRNA Biomarker
    YU-Husan Kuo et al, 2020, IEEE Open J. Nanotechnol. CrossRef
30. Non-Coding RNAs as Biomarkers and Therapeutic Targets for Diabetic Kidney Disease
    Yue-Yu Gu et al, 2021, Front. Pharmacol. CrossRef
31. A miniaturized, DNA-FET biosensor-based microfluidic system for quantification of two breast cancer biomarkers
    Chi-Chien Huang et al, 2021, Microfluid Nanofluid CrossRef
32. miRNAs as biomarkers for diagnosis of type 2 diabetes: A systematic review
    Luis Edgar González‐Sánchez et al, 2021, Journal of Diabetes CrossRef
33. MicroRNAs-1299, -126-3p and -30e-3p as Potential Diagnostic Biomarkers for Prediabetes.
    Cecil J Weale et al, 2021, Diagnostics (Basel) CrossRef
34. Circulating microRNA-122, microRNA-126-3p and microRNA-146a are associated with inflammation in patients with pre-diabetes and type 2 diabetes mellitus: A case control study.
    Fahime Zeinali et al, 2021, PLoS One CrossRef
35. Salivary microRNA-126 and 135a: a potentially non-invasive diagnostic biomarkers of type- 2 diabetes
    Yousef Khazaei Monfared et al, 2021, J Diabetes Metab Disord CrossRef
36. CircTLK1 Downregulation Attenuates High Glucose-Induced Human Mesangial Cell Injury by Blocking the AKT/NF-κB Pathway Through Sponging miR-126-5p/miR-204-5p
    Binghua Qiu et al, 2021, Biochem Genet CrossRef
37. Milk exosomes-mediated miR-31-5p delivery accelerates diabetic wound healing through promoting angiogenesis
    Chengqi Yan et al, 2022, Drug Delivery CrossRef
38. The Dynamics and Plasticity of Epigenetics in Diabetic Kidney Disease: Therapeutic Applications Vis-à-Vis
    Feng-Chih Kuo et al, 2022, IJMS CrossRef
39. Alteration in serum miR126 expression in healthy adults observing Navratri fast
    Nardeep Naithani et al, 2022, Medical Journal Armed Forces India CrossRef
40. Circulatory miR-126 expression as an epigenetic marker in diabetes mellitus; a systematic review & meta-analysis
    S.V. Athira et al, 2022, Gene Reports CrossRef
41. Circulating miRNAs in Type 2 Diabetic Patients with and without Albuminuria in Malaysia
    Siti Yazmin Zahari Sham et al, 2022, Kidney Blood Press Res CrossRef
42. Expression of whole blood miR-126-3p, -30a-5p, -1299, -182-5p and -30e-3p in chronic kidney disease in a South African community-based sample
    Dipuo D. Motshwari et al, 2022, Sci Rep CrossRef
43. Profile of urinary exosomal microRNAs and their contribution to diabetic kidney disease through a predictive classification model
    Ana K. González‐Palomo et al, 2022, Nephrology CrossRef
44. Interval training and Crataegus persica ameliorate diabetic nephropathy via miR-126/Nrf-2 mediated inhibition of stress oxidative in rats with diabetes after myocardial ischemia-reperfusion injury
    Masoumeh Asgari et al, 2022, Biomedicine & Pharmacotherapy CrossRef
45. Genomics, Proteomics and Metabolomics Approaches for Predicting Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients
    Siska Darmayanti et al, 2021, CDR CrossRef
46. miR-21-3p and miR-192-5p in patients with type 2 diabetic nephropathy
    Kadriye Akpınar et al, 2022 CrossRef
47. Polyphenols target miRNAs as a therapeutic strategy for diabetic complications
    Faezeh Malakoti et al, 2022, Critical Reviews in Food Science and Nutrition CrossRef
48. Roles of physical exercise-induced MiR-126 in cardiovascular health of type 2 diabetes
    Yixiao Ma et al, 2022, Diabetol Metab Syndr CrossRef
49. MicroRNAs Associated with Chronic Kidney Disease in the General Population and High-Risk Subgroups—A Systematic Review
    Dipuo D. Motshwari et al, 2023, IJMS CrossRef
50. The Role of MicroRNA-126 in Atherosclerotic Cardiovascular Diseases
    Panagiotis Theofilis et al, 2023, CMC CrossRef
51. Platycodin D inhibits HFD/STZ-induced diabetic nephropathy via inflammatory and apoptotic signaling pathways in C57BL/6 mice
    Qiong Shen et al, 2023, Journal of Ethnopharmacology CrossRef
52. The role of miRNAs carried by extracellular vesicles in type 2 diabetes and its complications
    Yining Chao et al, 2023, Journal of Diabetes CrossRef
53. LncRNA HOX transcript antisense RNA mediates hyperglycemic‐induced injury in the renal tubular epithelial cell via the miR‐126‐5pAkt axis
    Qiong Jiang et al, 2023, Aging Medicine CrossRef